BioWorld™ published by Clarivate Plc, a leading global provider of transformative intelligence, has been honored with nine 2024 APEX Awards for Publication Excellence. This remarkable achievement highlights BioWorld's unwavering commitment to journalistic excellence, data-driven analysis, and pioneering digital publishing.
Now in its 36th year, the APEX Awards recognize outstanding work by professional communicators in areas such as graphic design, editorial content, and overall communications excellence. This year's competition was particularly fierce, with over 1,100 entries. The nine awards bestowed upon BioWorld are a testament to its continued leadership and innovation in the field.
BioWorld received accolades across various categories, including writing, news, mental health, financial/investment, and economics. These awards underscore the publication’s diverse expertise and ability to deliver high-quality, impactful journalism that resonates with its audience.
The APEX Grand Awards honor outstanding works in each main category, while the Awards of Excellence recognize exceptional entries in the sub-categories. BioWorld’s multiple wins reflect its consistent performance and dedication to setting industry standards in professional communication.
BioWorld's success at the 2024 APEX Awards reaffirms its status as a premier source of transformative intelligence. By maintaining high standards in reporting and analysis, BioWorld continues to provide invaluable insights to its readers, helping them navigate the complexities of the biotech and pharmaceutical industries.
Click here to read the original press release.
